Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability

American Journal of Clinical Pathology

Volumn 123, Issue 4, 2005, Pages 562-570

  Miquel, Catherine ^a   Borrini, Francesco ^a   Grandjouan, Sophie ^a,b   Aupérin, Anne ^a   Viguier, Jérôme ^a   Velasco, Valérie ^a   Duvillard, Pierre ^a   Praz, Françoise ^a   Sabourin, Jean Christophe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Institut Cochin   (France)

Author keywords

Apoptosis; Bax; Colorectal cancer; Microsatellite instability

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; CANCER GROWTH; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 15744399807     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/JQ2X3RV3L8F9TGYW     Document Type: Article

References (34)

1. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153-164.
2. Gross A, McDonnell JM, Korsmeyer SJ. bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899-1911.
3. Adams JM, Cory S. The bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
4. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293-299.
5. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010-1014.
6. Oltvai ZN, Milliman CL, Korsmeyer SJ. bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
7. Letai A, Bassik MC, Walensky LD, et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2002;2:183-192.
8. Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol. 2002;3:83-88.
9. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002;62:2447-2454.
10. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the bax gene in colon cancers of the microsatellite mutator phenotype. Science. 1997;275:967-969.
11. Yin C, Knudson CM, Korsmeyer SJ, et al. bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 1997;385:637-640.
12. Theodorakis P, Lomonosova E, Chinnadurai G. Critical requirement of bax for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res. 2002;62:3373-3376.
13. Jansson A, Sun XF. bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J Clin Oncol. 2002;20:811-816.
14. De Angelis PM, Stokke T, Thorstensen L, et al. Apoptosis and expression of bax, bcl-x, and bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype. Mol Pathol. 1998;51:254-261.
15. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
16. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
17. Fallik D, Borrini F, Boige V, et al. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res. 2003;63:5738-5744.
18. Krajewski S, Blomqvist C, Franssila K, et al. Reduced expression of proapoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995;55:4471-4478.
19. Sturm I, Kohne CH, Wolff G, et al. Analysis of the p53/bax pathway in colorectal cancer: low bax is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol. 1999;17:1364-1374.
20. Krajewska M, Moss SF, Krajewski S, et al. Elevated expression of bcl-X and reduced bak in primary colorectal adenocarcinomas. Cancer Res. 1996;56:2422-2427.
21. Gervaz P, Cerottini JP, Bouzourene H, et al. Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer. Surgery. 2002;131:190-197.
22. Samowitz WS, Holden JA, Curtin K, et al. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol. 2001;158:1517-1524.
23. Michael-Robinson JM, Reid LE, Purdie DM, et al. Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer. Clin Cancer Res. 2001;7:2347-2356.
24. Yamamoto H, Sawai H, Weber TK, et al. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 1998;58:997-1003.
25. Sakao Y, Noro M, Sekine S, et al. Microsatellite instability and frameshift mutations in the bax gene in hereditary nonpolyposis colorectal carcinoma. Jpn J Cancer Res. 1998;89:1020-1027.
26. Yagi OK, Akiyama Y, Nomizu T, et al. Proapoptotic gene bax is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology. 1998;114:268-274.
27. Ouyang H, Furukawa T, Abe T, et al. The bax gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. Clin Cancer Res. 1998;4:1071-1074.
28. Calin GA, Gafa R, Tibiletti MG, et al. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGFbetaRII, bax, hMSH3, hMSH6, IGFIIR and blm genes. Int J Cancer. 2000;89:230-235.
29. Maurer CA, Friess H, Buhler SS, et al. Apoptosis inhibiting factor bcl-xL might be the crucial member of the bcl-2 gene family in colorectal cancer. Dig Dis Sci. 1998;43:2641-2648.
30. Paradiso A, Simone G, Lena MD, et al. Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer. Br J Cancer. 2001;84:651-658.
31. Ionov Y, Yamamoto H, Krajewski S, et al. Mutational inactivation of the proapoptotic gene bax confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci U S A. 2000;97:10872-10877.
32. Abdel-Rahman WM, Georgiades IB, Curtis LJ, et al. Role of bax mutations in mismatch repair-deficient colorectal carcinogenesis. Oncogene. 1999;18:2139-2142.
33. Barnetson R, Jass J, Tse R, et al. Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity. Genes Chromosomes Cancer. 2000;29:130-136.
34. Simms LA, Radford-Smith G, Biden KG, et al. Reciprocal relationship between the tumor suppressors p53 and bax in primary colorectal cancers. Oncogene. 1998;17:2003-2008.